Literature DB >> 8570614

A family of transmembrane proteins with homology to the MET-hepatocyte growth factor receptor.

E Maestrini1, L Tamagnone, P Longati, O Cremona, M Gulisano, S Bione, F Tamanini, B G Neel, D Toniolo, P M Comoglio.   

Abstract

In hunting for unknown genes on the human X chromosome, we identified a cDNA in Xq28 encoding a transmembrane protein (SEX) of 1871 amino acids. SEX shares significant homology with the extracellular domain of the receptors encoded by the oncogenes MET, RON, and SEA [hepatocyte growth factor (HGF) receptor family]. Further screenings of cDNA libraries identified three additional sequences closely related to SEX: these were named SEP, OCT, and NOV and were located on human chromosomes 3p, 1, and 3q, respectively. The proteins encoded by these genes contain large cytoplasmic domains characterized by a distinctive highly conserved sequence (SEX domain). Northern blot analysis revealed different expression of the SEX family of genes in fetal tissues, with SEX, OCT, and NOV predominantly expressed in brain, and SEP expressed at highest levels in kidney. In situ hybridization analysis revealed that SEX has a distinctive pattern of expression in the developing nervous system of the mouse, where it is found in postmitotic neurons from the first stages of neuronal differentiation (9.5 day postcoitus). The SEX protein (220 kDa) is glycosylated and exposed at the cell surface. Unlike the receptors of the HGF family, p220SEX, a MET-SEX chimera or a constitutively dimerized TPR-SEX does not show tyrosine kinase activity. These data define a gene family (SEX family) involved in the development of neural and epithelial tissues, which encodes putative receptors with unexpected enzymatic or binding properties.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8570614      PMCID: PMC40111          DOI: 10.1073/pnas.93.2.674

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  40 in total

Review 1.  Protein modules.

Authors:  M Baron; D G Norman; I D Campbell
Journal:  Trends Biochem Sci       Date:  1991-01       Impact factor: 13.807

2.  c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.

Authors:  C Ponzetto; S Giordano; F Peverali; G Della Valle; M L Abate; G Vaula; P M Comoglio
Journal:  Oncogene       Date:  1991-04       Impact factor: 9.867

Review 3.  Growth factors in development, transformation, and tumorigenesis.

Authors:  M Cross; T M Dexter
Journal:  Cell       Date:  1991-01-25       Impact factor: 41.582

4.  Prokaryotic expression cloning of a novel human tyrosine kinase.

Authors:  J F Beeler; W J LaRochelle; M Chedid; S R Tronick; S A Aaronson
Journal:  Mol Cell Biol       Date:  1994-02       Impact factor: 4.272

5.  Tyrosine kinase receptor indistinguishable from the c-met protein.

Authors:  S Giordano; C Ponzetto; M F Di Renzo; C S Cooper; P M Comoglio
Journal:  Nature       Date:  1989-05-11       Impact factor: 49.962

6.  A simple method for displaying the hydropathic character of a protein.

Authors:  J Kyte; R F Doolittle
Journal:  J Mol Biol       Date:  1982-05-05       Impact factor: 5.469

7.  Overexpression and amplification of the met/HGF receptor gene during the progression of colorectal cancer.

Authors:  M F Di Renzo; M Olivero; A Giacomini; H Porte; E Chastre; L Mirossay; B Nordlinger; S Bretti; S Bottardi; S Giordano
Journal:  Clin Cancer Res       Date:  1995-02       Impact factor: 12.531

8.  RON is a heterodimeric tyrosine kinase receptor activated by the HGF homologue MSP.

Authors:  G Gaudino; A Follenzi; L Naldini; C Collesi; M Santoro; K A Gallo; P J Godowski; P M Comoglio
Journal:  EMBO J       Date:  1994-08-01       Impact factor: 11.598

9.  Hepatocyte growth factor induces proliferation and differentiation of multipotent and erythroid hemopoietic progenitors.

Authors:  F Galimi; G P Bagnara; L Bonsi; E Cottone; A Follenzi; A Simeone; P M Comoglio
Journal:  J Cell Biol       Date:  1994-12       Impact factor: 10.539

10.  The Met receptor tyrosine kinase transduces motility, proliferation, and morphogenic signals of scatter factor/hepatocyte growth factor in epithelial cells.

Authors:  K M Weidner; M Sachs; W Birchmeier
Journal:  J Cell Biol       Date:  1993-04       Impact factor: 10.539

View more
  35 in total

1.  mRNA differential display identification of vascular smooth muscle early response genes regulated by PDGF.

Authors:  Joe O Minta; James J Yun; Oluyomi Kabiawu; Jabbal Jones
Journal:  Mol Cell Biochem       Date:  2006-01       Impact factor: 3.396

Review 2.  Plexin structures are coming: opportunities for multilevel investigations of semaphorin guidance receptors, their cell signaling mechanisms, and functions.

Authors:  Prasanta K Hota; Matthias Buck
Journal:  Cell Mol Life Sci       Date:  2012-06-29       Impact factor: 9.261

Review 3.  Divergent roles of Plexin D1 in cancer.

Authors:  Sneha Vivekanadhan; Debabrata Mukhopadhyay
Journal:  Biochim Biophys Acta Rev Cancer       Date:  2019-05-30       Impact factor: 10.680

Review 4.  Biology and function of neuroimmune semaphorins 4A and 4D.

Authors:  EusebiusHenry Nkyimbeng-Takwi; Svetlana P Chapoval
Journal:  Immunol Res       Date:  2011-05       Impact factor: 2.829

5.  Semaphorin4D-PlexinB1 Signaling Attenuates Photoreceptor Outer Segment Phagocytosis by Reducing Rac1 Activity of RPE Cells.

Authors:  Ayelen Bulloj; Arvydas Maminishkis; Masayuki Mizui; Silvia C Finnemann
Journal:  Mol Neurobiol       Date:  2017-06-17       Impact factor: 5.590

Review 6.  Tyrosine phosphorylation in semaphorin signalling: shifting into overdrive.

Authors:  Mélanie Franco; Luca Tamagnone
Journal:  EMBO Rep       Date:  2008-07-25       Impact factor: 8.807

Review 7.  MET as a target for treatment of chest tumors.

Authors:  Nicole A Cipriani; Oyewale O Abidoye; Everett Vokes; Ravi Salgia
Journal:  Lung Cancer       Date:  2008-07-30       Impact factor: 5.705

Review 8.  c-Met and hepatocyte growth factor: potential as novel targets in cancer therapy.

Authors:  Martin Sattler; Ravi Salgia
Journal:  Curr Oncol Rep       Date:  2007-03       Impact factor: 5.075

9.  Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect.

Authors:  Emely Castro-Rivera; Sophia Ran; Philip Thorpe; John D Minna
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-23       Impact factor: 11.205

10.  Insights into oncogenic mutations of plexin-B1 based on the solution structure of the Rho GTPase binding domain.

Authors:  Yufeng Tong; Prasanta K Hota; Mehdi Bagheri Hamaneh; Matthias Buck
Journal:  Structure       Date:  2008-02       Impact factor: 5.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.